Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

S-Tenatoprazole

Drug Profile

S-Tenatoprazole

Alternative Names: Benatoprazole; S-Tenatoprazole-Na; sTU-199; STU-Na; TU-199

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Developer Abbott Japan; Mitsubishi Pharma Corporation; Negma SAS; Steba Laboratories
  • Class Antiulcers; Gastric antisecretories; Imidazoles; Pyridines; Small molecules
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Suspended Gastro-oesophageal reflux
  • Discontinued Peptic ulcer; Zollinger-Ellison syndrome

Most Recent Events

  • 30 Apr 2018 Discontinued - Phase-I for Gastro-oesophageal reflux in Europe (PO) (Mitsubishi Tanabe Pharma pipeline, May 2018)
  • 31 Jul 2017 Phase-I clinical trials in Gastro-oesophageal reflux in Europe (PO) (Mitsubishi Tanabe Pharma Corporation pipeline, July 2017)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Gastro-oesophageal-reflux in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top